1 Uterine Fibroid Embolization Agents Market Overview 1.1 Product Overview and Scope of Uterine Fibroid Embolization Agents 1.2 Uterine Fibroid Embolization Agents Segment by Type 1.2.1 Global Uterine Fibroid Embolization Agents Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Gelatin Sponge 1.2.3 Polyvinyl Alcohol (PVA) Particles 1.2.4 Trisacryl Gelatin Microspheres (TAGM) 1.2.5 Polymethyl Methacrylate (PMMA) Microspheres 1.2.6 Others 1.3 Uterine Fibroid Embolization Agents Segment by Application 1.3.1 Uterine Fibroid Embolization Agents Sales Comparison by Application: (2021-2027) 1.3.2 Clinical Research Institutes 1.3.3 Hospital 1.3.4 Surgical Centers 1.3.5 Others 1.4 Global Uterine Fibroid Embolization Agents Market Size Estimates and Forecasts 1.4.1 Global Uterine Fibroid Embolization Agents Revenue 2016-2027 1.4.2 Global Uterine Fibroid Embolization Agents Sales 2016-2027 1.4.3 Uterine Fibroid Embolization Agents Market Size by Region: 2016 Versus 2021 Versus 2027 2 Uterine Fibroid Embolization Agents Market Competition by Manufacturers 2.1 Global Uterine Fibroid Embolization Agents Sales Market Share by Manufacturers (2016-2021) 2.2 Global Uterine Fibroid Embolization Agents Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Uterine Fibroid Embolization Agents Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Uterine Fibroid Embolization Agents Manufacturing Sites, Area Served, Product Type 2.5 Uterine Fibroid Embolization Agents Market Competitive Situation and Trends 2.5.1 Uterine Fibroid Embolization Agents Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Uterine Fibroid Embolization Agents Players Market Share by Revenue 2.5.3 Global Uterine Fibroid Embolization Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Uterine Fibroid Embolization Agents Retrospective Market Scenario by Region 3.1 Global Uterine Fibroid Embolization Agents Retrospective Market Scenario in Revenue by Region: 2016-2021 3.2 Global Uterine Fibroid Embolization Agents Retrospective Market Scenario in Sales by Region: 2016-2021 3.3 North America Uterine Fibroid Embolization Agents Market Facts & Figures by Country 3.3.1 North America Uterine Fibroid Embolization Agents Sales by Country 3.3.2 North America Uterine Fibroid Embolization Agents Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Uterine Fibroid Embolization Agents Market Facts & Figures by Country 3.4.1 Europe Uterine Fibroid Embolization Agents Sales by Country 3.4.2 Europe Uterine Fibroid Embolization Agents Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Uterine Fibroid Embolization Agents Market Facts & Figures by Region 3.5.1 Asia Pacific Uterine Fibroid Embolization Agents Sales by Region 3.5.2 Asia Pacific Uterine Fibroid Embolization Agents Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Uterine Fibroid Embolization Agents Market Facts & Figures by Country 3.6.1 Latin America Uterine Fibroid Embolization Agents Sales by Country 3.6.2 Latin America Uterine Fibroid Embolization Agents Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Uterine Fibroid Embolization Agents Market Facts & Figures by Country 3.7.1 Middle East and Africa Uterine Fibroid Embolization Agents Sales by Country 3.7.2 Middle East and Africa Uterine Fibroid Embolization Agents Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Uterine Fibroid Embolization Agents Historic Market Analysis by Type 4.1 Global Uterine Fibroid Embolization Agents Sales Market Share by Type (2016-2021) 4.2 Global Uterine Fibroid Embolization Agents Revenue Market Share by Type (2016-2021) 4.3 Global Uterine Fibroid Embolization Agents Price by Type (2016-2021) 5 Global Uterine Fibroid Embolization Agents Historic Market Analysis by Application 5.1 Global Uterine Fibroid Embolization Agents Sales Market Share by Application (2016-2021) 5.2 Global Uterine Fibroid Embolization Agents Revenue Market Share by Application (2016-2021) 5.3 Global Uterine Fibroid Embolization Agents Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Astellas Pharma 6.1.1 Astellas Pharma Corporation Information 6.1.2 Astellas Pharma Description and Business Overview 6.1.3 Astellas Pharma Uterine Fibroid Embolization Agents Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Astellas Pharma Product Portfolio 6.1.5 Astellas Pharma Recent Developments/Updates 6.2 Nippon Kayaku 6.2.1 Nippon Kayaku Corporation Information 6.2.2 Nippon Kayaku Description and Business Overview 6.2.3 Nippon Kayaku Uterine Fibroid Embolization Agents Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Nippon Kayaku Product Portfolio 6.2.5 Nippon Kayaku Recent Developments/Updates 6.3 Pfizer 6.3.1 Pfizer Corporation Information 6.3.2 Pfizer Description and Business Overview 6.3.3 Pfizer Uterine Fibroid Embolization Agents Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Pfizer Product Portfolio 6.3.5 Pfizer Recent Developments/Updates 6.4 Boston Scientific Corporation 6.4.1 Boston Scientific Corporation Corporation Information 6.4.2 Boston Scientific Corporation Description and Business Overview 6.4.3 Boston Scientific Corporation Uterine Fibroid Embolization Agents Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Boston Scientific Corporation Product Portfolio 6.4.5 Boston Scientific Corporation Recent Developments/Updates 6.5 Merit Medical Systems 6.5.1 Merit Medical Systems Corporation Information 6.5.2 Merit Medical Systems Description and Business Overview 6.5.3 Merit Medical Systems Uterine Fibroid Embolization Agents Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Merit Medical Systems Product Portfolio 6.5.5 Merit Medical Systems Recent Developments/Updates 6.6 Cook Medical 6.6.1 Cook Medical Corporation Information 6.6.2 Cook Medical Description and Business Overview 6.6.3 Cook Medical Uterine Fibroid Embolization Agents Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Cook Medical Product Portfolio 6.6.5 Cook Medical Recent Developments/Updates 7 Uterine Fibroid Embolization Agents Manufacturing Cost Analysis 7.1 Uterine Fibroid Embolization Agents Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Uterine Fibroid Embolization Agents 7.4 Uterine Fibroid Embolization Agents Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Uterine Fibroid Embolization Agents Distributors List 8.3 Uterine Fibroid Embolization Agents Customers 9 Uterine Fibroid Embolization Agents Market Dynamics 9.1 Uterine Fibroid Embolization Agents Industry Trends 9.2 Uterine Fibroid Embolization Agents Growth Drivers 9.3 Uterine Fibroid Embolization Agents Market Challenges 9.4 Uterine Fibroid Embolization Agents Market Restraints 10 Global Market Forecast 10.1 Uterine Fibroid Embolization Agents Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Uterine Fibroid Embolization Agents by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Uterine Fibroid Embolization Agents by Type (2022-2027) 10.2 Uterine Fibroid Embolization Agents Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Uterine Fibroid Embolization Agents by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Uterine Fibroid Embolization Agents by Application (2022-2027) 10.3 Uterine Fibroid Embolization Agents Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Uterine Fibroid Embolization Agents by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Uterine Fibroid Embolization Agents by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Uterine Fibroid Embolization Agents Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Uterine Fibroid Embolization Agents Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Uterine Fibroid Embolization Agents Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Uterine Fibroid Embolization Agents Covered in This Study Table 5. Global Uterine Fibroid Embolization Agents Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Uterine Fibroid Embolization Agents Sales Share by Manufacturers (2016-2021) Table 7. Global Uterine Fibroid Embolization Agents Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Uterine Fibroid Embolization Agents Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Uterine Fibroid Embolization Agents Average Price (USD/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Uterine Fibroid Embolization Agents Manufacturing Sites and Area Served Table 11. Manufacturers Uterine Fibroid Embolization Agents Product Type Table 12. Global Uterine Fibroid Embolization Agents Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Uterine Fibroid Embolization Agents by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Uterine Fibroid Embolization Agents as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Uterine Fibroid Embolization Agents Sales by Region (2016-2021) & (K Units) Table 16. Global Uterine Fibroid Embolization Agents Sales Market Share by Region (2016-2021) Table 17. Global Uterine Fibroid Embolization Agents Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Uterine Fibroid Embolization Agents Sales by Country (2016-2021) & (K Units) Table 19. North America Uterine Fibroid Embolization Agents Sales Market Share by Country (2016-2021) Table 20. North America Uterine Fibroid Embolization Agents Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Uterine Fibroid Embolization Agents Revenue Market Share by Country (2016-2021) Table 22. Europe Uterine Fibroid Embolization Agents Sales by Country (2016-2021) & (K Units) Table 23. Europe Uterine Fibroid Embolization Agents Sales Market Share by Country (2016-2021) Table 24. Europe Uterine Fibroid Embolization Agents Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Uterine Fibroid Embolization Agents Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Uterine Fibroid Embolization Agents Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Uterine Fibroid Embolization Agents Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Uterine Fibroid Embolization Agents Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Uterine Fibroid Embolization Agents Revenue Market Share by Region (2016-2021) Table 30. Latin America Uterine Fibroid Embolization Agents Sales by Country (2016-2021) & (K Units) Table 31. Latin America Uterine Fibroid Embolization Agents Sales Market Share by Country (2016-2021) Table 32. Latin America Uterine Fibroid Embolization Agents Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Uterine Fibroid Embolization Agents Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Uterine Fibroid Embolization Agents Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Uterine Fibroid Embolization Agents Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Uterine Fibroid Embolization Agents Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Uterine Fibroid Embolization Agents Revenue Market Share by Country (2016-2021) Table 38. Global Uterine Fibroid Embolization Agents Sales (K Units) by Type (2016-2021) Table 39. Global Uterine Fibroid Embolization Agents Sales Market Share by Type (2016-2021) Table 40. Global Uterine Fibroid Embolization Agents Revenue (Million US$) by Type (2016-2021) Table 41. Global Uterine Fibroid Embolization Agents Revenue Share by Type (2016-2021) Table 42. Global Uterine Fibroid Embolization Agents Price (USD/Unit) by Type (2016-2021) Table 43. Global Uterine Fibroid Embolization Agents Sales (K Units) by Application (2016-2021) Table 44. Global Uterine Fibroid Embolization Agents Sales Market Share by Application (2016-2021) Table 45. Global Uterine Fibroid Embolization Agents Revenue (Million US$) by Application (2016-2021) Table 46. Global Uterine Fibroid Embolization Agents Revenue Share by Application (2016-2021) Table 47. Global Uterine Fibroid Embolization Agents Price (USD/Unit) by Application (2016-2021) Table 48. Astellas Pharma Corporation Information Table 49. Astellas Pharma Description and Business Overview Table 50. Astellas Pharma Uterine Fibroid Embolization Agents Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 51. Astellas Pharma Uterine Fibroid Embolization Agents Product Table 52. Astellas Pharma Recent Developments/Updates Table 53. Nippon Kayaku Corporation Information Table 54. Nippon Kayaku Description and Business Overview Table 55. Nippon Kayaku Uterine Fibroid Embolization Agents Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 56. Nippon Kayaku Uterine Fibroid Embolization Agents Product Table 57. Nippon Kayaku Recent Developments/Updates Table 58. Pfizer Corporation Information Table 59. Pfizer Description and Business Overview Table 60. Pfizer Uterine Fibroid Embolization Agents Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 61. Pfizer Uterine Fibroid Embolization Agents Product Table 62. Pfizer Recent Developments/Updates Table 63. Boston Scientific Corporation Corporation Information Table 64. Boston Scientific Corporation Description and Business Overview Table 65. Boston Scientific Corporation Uterine Fibroid Embolization Agents Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 66. Boston Scientific Corporation Uterine Fibroid Embolization Agents Product Table 67. Boston Scientific Corporation Recent Developments/Updates Table 68. Merit Medical Systems Corporation Information Table 69. Merit Medical Systems Description and Business Overview Table 70. Merit Medical Systems Uterine Fibroid Embolization Agents Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 71. Merit Medical Systems Uterine Fibroid Embolization Agents Product Table 72. Merit Medical Systems Recent Developments/Updates Table 73. Cook Medical Corporation Information Table 74. Cook Medical Description and Business Overview Table 75. Cook Medical Uterine Fibroid Embolization Agents Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 76. Cook Medical Uterine Fibroid Embolization Agents Product Table 77. Cook Medical Recent Developments/Updates Table 78. Production Base and Market Concentration Rate of Raw Material Table 79. Key Suppliers of Raw Materials Table 80. Uterine Fibroid Embolization Agents Distributors List Table 81. Uterine Fibroid Embolization Agents Customers List Table 82. Uterine Fibroid Embolization Agents Market Trends Table 83. Uterine Fibroid Embolization Agents Growth Drivers Table 84. Uterine Fibroid Embolization Agents Market Restraints Table 85. Global Uterine Fibroid Embolization Agents Sales Forecast by Type (2022-2027) & (K Units) Table 86. Global Uterine Fibroid Embolization Agents Sales Market Share Forecast by Type (2022-2027) Table 87. Global Uterine Fibroid Embolization Agents Revenue Forecast by Type (2022-2027) & (US$ Million) Table 88. Global Uterine Fibroid Embolization Agents Revenue Market Share Forecast by Type (2022-2027) Table 89. Global Uterine Fibroid Embolization Agents Sales Forecast by Application (2022-2027) & (K Units) Table 90. Global Uterine Fibroid Embolization Agents Sales Market Share Forecast by Application (2022-2027) Table 91. Global Uterine Fibroid Embolization Agents Revenue Forecast by Application (2022-2027) & (US$ Million) Table 92. Global Uterine Fibroid Embolization Agents Revenue Market Share Forecast by Application (2022-2027) Table 93. Global Uterine Fibroid Embolization Agents Sales Forecast by Region (2022-2027) & (K Units) Table 94. Global Uterine Fibroid Embolization Agents Sales Market Share Forecast by Region (2022-2027) Table 95. Global Uterine Fibroid Embolization Agents Revenue Forecast by Region (2022-2027) & (US$ Million) Table 96. Global Uterine Fibroid Embolization Agents Revenue Market Share Forecast by Region (2022-2027) Table 97. Research Programs/Design for This Report Table 98. Key Data Information from Secondary Sources Table 99. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Uterine Fibroid Embolization Agents Figure 2. Global Uterine Fibroid Embolization Agents Market Share by Type in 2020 & 2027 Figure 3. Gelatin Sponge Product Picture Figure 4. Polyvinyl Alcohol (PVA) Particles Product Picture Figure 5. Trisacryl Gelatin Microspheres (TAGM) Product Picture Figure 6. Polymethyl Methacrylate (PMMA) Microspheres Product Picture Figure 7. Others Product Picture Figure 8. Global Uterine Fibroid Embolization Agents Market Share by Application in 2020 & 2027 Figure 9. Clinical Research Institutes Figure 10. Hospital Figure 11. Surgical Centers Figure 12. Others Figure 13. Global Uterine Fibroid Embolization Agents Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Uterine Fibroid Embolization Agents Market Size 2016-2027 (US$ Million) Figure 15. Global Uterine Fibroid Embolization Agents Sales 2016-2027 (K Units) Figure 16. Global Uterine Fibroid Embolization Agents Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 17. Uterine Fibroid Embolization Agents Sales Share by Manufacturers in 2020 Figure 18. Global Uterine Fibroid Embolization Agents Revenue Share by Manufacturers in 2020 Figure 19. The Global 5 and 10 Largest Uterine Fibroid Embolization Agents Players: Market Share by Revenue in 2020 Figure 20. Uterine Fibroid Embolization Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 21. Global Uterine Fibroid Embolization Agents Sales Market Share by Region (2016-2021) Figure 22. Global Uterine Fibroid Embolization Agents Sales Market Share by Region in 2020 Figure 23. Global Uterine Fibroid Embolization Agents Revenue Market Share by Region (2016-2021) Figure 24. Global Uterine Fibroid Embolization Agents Revenue Market Share by Region in 2020 Figure 25. U.S. Uterine Fibroid Embolization Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Canada Uterine Fibroid Embolization Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Germany Uterine Fibroid Embolization Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. France Uterine Fibroid Embolization Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. U.K. Uterine Fibroid Embolization Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. Italy Uterine Fibroid Embolization Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. Russia Uterine Fibroid Embolization Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. China Uterine Fibroid Embolization Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Japan Uterine Fibroid Embolization Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. South Korea Uterine Fibroid Embolization Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. India Uterine Fibroid Embolization Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Australia Uterine Fibroid Embolization Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Taiwan Uterine Fibroid Embolization Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Indonesia Uterine Fibroid Embolization Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Thailand Uterine Fibroid Embolization Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Malaysia Uterine Fibroid Embolization Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Philippines Uterine Fibroid Embolization Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Vietnam Uterine Fibroid Embolization Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Mexico Uterine Fibroid Embolization Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Brazil Uterine Fibroid Embolization Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Argentina Uterine Fibroid Embolization Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Turkey Uterine Fibroid Embolization Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Saudi Arabia Uterine Fibroid Embolization Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. U.A.E Uterine Fibroid Embolization Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 49. Sales Market Share of Uterine Fibroid Embolization Agents by Type (2016-2021) Figure 50. Sales Market Share of Uterine Fibroid Embolization Agents by Application (2016-2021) Figure 51. Sales Market Share of Uterine Fibroid Embolization Agents by Application in 2020 Figure 52. Revenue Share of Uterine Fibroid Embolization Agents by Application (2016-2021) Figure 53. Revenue Share of Uterine Fibroid Embolization Agents by Application in 2020 Figure 54. Manufacturing Cost Structure of Uterine Fibroid Embolization Agents Figure 55. Manufacturing Process Analysis of Uterine Fibroid Embolization Agents Figure 56. Uterine Fibroid Embolization Agents Industrial Chain Analysis Figure 57. Channels of Distribution Figure 58. Distributors Profiles Figure 59. Bottom-up and Top-down Approaches for This Report Figure 60. Data Triangulation Figure 61. Key Executives Interviewed

Astellas Pharma Nippon Kayaku Pfizer Boston Scientific Corporation Merit Medical Systems Cook Medical